SynthesisJornal brasileiro de nefrologia
The role of cystatin C in kidney injury in children and adolescents with type 1 diabetes mellitus: a systematic review.
Synthesis in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDiabetic kidney disease (DKD) is a major complication of type 1 diabetes mellitus (T1D). In clinical practice, albuminuria and reduced estimated glomerular filtration rate (eGFR) are the main characteristics of DKD. Later studies revealed that interstitial damage is also observed as DKD occurs. Therefore, the application of a biomarker for early DKD detection was critical. This systematic review aimed to summarize the literature about the prognostic role of cystatin C in kidney injury in children and adolescents with T1D.
methodsFrom inception until September 24, 2024, an extensive literature search through major databases (MEDLINE/PubMed, Cochrane Library, and Scopus) was carried out to investigate the prognostic role of cystatin C in kidney injury in pediatric patients with T1D. The mean difference was used for continuous outcomes with 95%CI. A p < 0.05 was considered statistically significant. A quality assessment of included studies was conducted using the Newcastle-Ottawa Scale.
resultsWe included eleven studies with 2199 participants in this systematic review. The meta-analysis included four studies. No statistically significant difference was observed in serum cystatin C levels between patients with T1D and the control group.
conclusionAlthough individual studies showed some benefit of using serum cystatin C for the prognosis of DKD in pediatric patients with T1D, the meta-analysis of included studies reached no statistical significance. Future clinical studies should focus on the prognostic role of cystatin C (serum and urinary) in identifying kidney injury in pediatric patients with T1D.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.